Taste Or Smell Or Chemical Irritation To The Eye, Nose, Or Mouth Feature Patents (Class 424/10.4)
-
Patent number: 11759408Abstract: The invention relates to a dental cleaning wipe comprising a non-woven textile support impregnated with a dental hygiene composition containing mechanically-broken microcapsules, the content of which is released by breaking the wall, as well as controlled-release microcapsules, the content of which is released by permeation through the wall, the walls of said microcapsules being water-insoluble.Type: GrantFiled: July 20, 2018Date of Patent: September 19, 2023Inventor: Stephane Bochenek
-
Patent number: 11650030Abstract: A lubric gel composition for personal defense includes a fatty acid at a concentration ranging from 5 wt % to 10 wt % of the composition, a thickening agent at a concentration ranging from 1.75 wt % to 8.75 wt % of the composition, a detergent at a concentration ranging from 1.03 wt % to 4.07 wt % of the composition, a surfactant at a concentration ranging from 2 wt % to 15 wt % of the composition, and water at a concentration ranging from 66 wt % to 90.21 wt % of the composition.Type: GrantFiled: April 22, 2022Date of Patent: May 16, 2023Inventor: David Daniel Rankin, Sr.
-
Patent number: 11129363Abstract: The subject invention provides the materials and methods for synthesizing novel training devices for biological detectors, such as canines, to locate a specific material by recognizing a characteristic scent associated with the material. In an exemplary embodiment, the training devices encapsulate at least one active odorant of certain illicit materials, such as cocaine, within a sol-gel polymer network. By manipulating the process of molecular encapsulation and polymer network synthesis, the novel training devices can reduce the influence of contaminants and dissipate the encapsulated odorant in a controlled fashion, allowing for the added benefit of improved shelf-life as compared to currently available training devices.Type: GrantFiled: May 9, 2016Date of Patent: September 28, 2021Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: Kenneth G. Furton, Michelle Cerreta, Abuzar Kabir
-
Patent number: 11103458Abstract: The present invention provides an abuse deterrent oral fixed-dose composition, comprising a stimulant or opioid and an abuse deterrent active, wherein the abuse deterrent active is configured to be bioavailable only when the composition is crushed, ground or dissolved.Type: GrantFiled: May 11, 2016Date of Patent: August 31, 2021Assignee: 4P-PharmaInventors: Yoram Sela, Itschak Lamensdorf
-
Patent number: 10155044Abstract: Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse comprising at least 10% by weight hydroxypropylcellulose; polyethylene oxide; and a disintegrant selected from the group consisting of crospovidone, sodium starch glycolate and croscarmellose sodium; wherein the ratio of hydroxypropylcellulose to polyethylene oxide on a weight basis is between about 10:1 and 1:10.Type: GrantFiled: February 7, 2017Date of Patent: December 18, 2018Assignee: Acura Pharmaceuticals, Inc.Inventors: Ronald L. Leech, Rachelle L. Hall Yung, Albert W. Brzeczko
-
Patent number: 9918909Abstract: A composition comprising a film or a plurality of film fragments entrained in a carrier is disclosed. The film or plurality of film fragments can comprise a functional material. The film or plurality of film fragments can comprise repeated shapes. Also disclosed is a composition comprising a plurality of discernable lamellar fragments entrained in a carrier. Also disclosed is a method for administering a functional material to a human or animal subject in need thereof, the method comprising applying to the subject a composition comprising a film or a plurality of film fragments entrained in a carrier, wherein the film comprises the functional material.Type: GrantFiled: December 16, 2004Date of Patent: March 20, 2018Assignee: Colgate-Palmolive CompanyInventors: Thomas J Boyd, Guofeng Xu, M. Teresa R Carale, Beth Ann Boff
-
Patent number: 9757466Abstract: Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse comprising at least 10% by weight hydroxypropylcellulose; polyethylene oxide; and a disintegrant selected from the group consisting of crospovidone, sodium starch glycolate and croscarmellose sodium; wherein the ratio of hydroxypropylcellulose to polyethylene oxide on a weight basis is between about 10:1 and 1:10.Type: GrantFiled: November 24, 2014Date of Patent: September 12, 2017Assignee: ACURA PHARMACEUTICALS, INC.Inventors: Ronald L. Leech, Rachelle L. Hall Yung, Albert W. Brzeczko
-
Patent number: 9752107Abstract: A composition, containing a carrier medium and particles based on a metal compound with a weight-average particle diameter of 1 nm to 10 ?m is useful to clean metal or ceramic surfaces which are part of a dental restoration or of an implant abutment.Type: GrantFiled: January 18, 2011Date of Patent: September 5, 2017Assignee: Ivoclar Vivadent AGInventors: Thorsten Bock, Ulrich Salz, Volker Rheinberger
-
Patent number: 8968706Abstract: The invention is directed to a method of detecting a biological substance in the nasal secretion and diagnosing a disease following the detection of the biological substance wherein the biological substance is not related to a respiratory disease. The invention also provides treatment of the diseases following the detection of the biological substance and/or diagnosis of the disease. In some embodiments, the diseases are cancer, hepatitis, smell loss, taste loss, diabetes, and leprosy. The invention also provides a kit for diagnosing a disease. The present invention includes methods of analyzing samples from the nose for the detection of biological substances. In particular, nasal secretion or nasal mucus is collected and analyzed for biological substances. The results of this analysis are then suitable for use in diagnosis, prognosis, and determination of suitability of therapeutic interventions.Type: GrantFiled: July 1, 2013Date of Patent: March 3, 2015Inventor: Robert I. Henkin
-
Publication number: 20140356294Abstract: The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse and optionally physiologically acceptable adjuvants. The invention also relates to a corresponding method for producing said dosage form.Type: ApplicationFiled: August 13, 2014Publication date: December 4, 2014Applicant: GRÜNENTHAL GMBHInventors: Elisabeth ARKENAU-MARIC, Johannes BARTHOLOMÄUS, Heinrich KUGELMANN
-
Publication number: 20140314681Abstract: A hair regrowth system consisting of sensitization, growth, and maintenance kits for alopecia areata and related alopecia balding conditions. Graduated doses of specific engineered and or extracted haptens are included in a sensitization kit for initiating immune system response in hairless areas. A growth kit containing topical hormones to increase papilla size and vigor and a maintenance kit to sustain immune system response and papilla size and vigor for the long term are included in some embodiments.Type: ApplicationFiled: February 26, 2014Publication date: October 23, 2014Inventor: George Davey
-
Publication number: 20140294736Abstract: A dental brushing composition including a brushing composition base additionally containing a plurality of microparticles, the particles comprising a core, a coating essentially completely surrounding the core, and two different flavors, a general flavor and an indicator flavor, the general flavor being in the coating and the indicator flavor in the core, the coating being essentially completely soluble under brushing conditions in a desired brushing time. The composition signals when a desired brushing time has been achieved by a noticeable change in flavor.Type: ApplicationFiled: November 12, 2012Publication date: October 2, 2014Applicant: Givaudan S.A.Inventors: Mary Amanda Mckee, Theodore T. Pearl
-
Publication number: 20140227197Abstract: Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms that deliver a therapeutic amount of active drug in a delayed and controlled release formulation. The dosage form can be administered at night and drug release is delayed for from 5 to 8 hours or longer, followed by a prolonged release.Type: ApplicationFiled: April 17, 2014Publication date: August 14, 2014Inventors: David Lickrish, Feng Zhang
-
Patent number: 8764715Abstract: Test methods for assessing irritation of portions of skin are provided. The method may include irritating a portion of skin by contacting the portion of skin with a chemical irritant; irritating the portion of skin by physical irritation; and assessing erythema or dryness of the portion of skin after irritating the steps. Alternatively, the method may include irritating a portion of skin with a chemical irritant; irritating the portion of skin by physical irritation; treating the irritated portion of skin by wiping the irritated portion of skin with a test sample; and assessing erythema or dryness of the portion of skin after the wiping step. A method of irritating a portion of skin to assess one of erythema and dryness may include irritating a portion of skin with a chemical irritant and irritating the portion of skin by physical irritation.Type: GrantFiled: July 28, 2011Date of Patent: July 1, 2014Assignee: The Procter & Gamble ComapnyInventor: Miranda Aref Farage
-
Publication number: 20140170079Abstract: The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse. The invention also relates to a corresponding method for producing said dosage form.Type: ApplicationFiled: December 23, 2013Publication date: June 19, 2014Applicant: GRUENENTHAL GMBHInventors: Elisabeth ARKENAU MARIC, Johannes BARTHOLOMAEUS, Heinrich KUGELMANN
-
Publication number: 20140105830Abstract: The present invention relates to an abuse-proofed, thermoformed dosage form containing, in addition to one or more active ingredients with abuse potential optionally together with physiologically acceptable auxiliary substances, at least one synthetic or natural polymer with a breaking strength of at least 500 N and to a process for the production thereof.Type: ApplicationFiled: December 23, 2013Publication date: April 17, 2014Applicant: GRUENENTHAL GMBHInventors: Johannes BARTHOLOMÄUS, Heinrich KUGELMANN, Elisabeth ARKENAU MARIC
-
Publication number: 20140086847Abstract: The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse and optionally physiologically acceptable adjuvants. The invention also relates to a corresponding method for producing said dosage form.Type: ApplicationFiled: November 27, 2013Publication date: March 27, 2014Applicant: GRUNENTHAL GMBHInventors: Elisabeth ARKENAU MARIC, Johannes BARTHOLOMÄUS, Heinrich KUGELMANN
-
Publication number: 20130266520Abstract: The present invention relates to rapidly dissolving edible film dosage form incorporating a physical-chemical identifier and/or indicia. The physical-chemical identifier and/or indicia may correspond to an active ingredient that may be evenly distributed throughout the film. The physical-chemical identifier and/or indicia may be associated with at least one section of the film composition and/or associated with a sealed pouch or package containing the film composition and provide information to the consumer, practitioner, producer or regulator that is relevant to the edible film dosage form.Type: ApplicationFiled: May 27, 2011Publication date: October 10, 2013Applicant: MONOSOL RX, LLCInventors: Richard C. Fuisz, Madhu Hariharan, Arlie Beuford Bogue, Greg Slominski
-
Publication number: 20130171075Abstract: The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse. The invention also relates to a corresponding method for producing said dosage form.Type: ApplicationFiled: December 21, 2012Publication date: July 4, 2013Applicant: GRUNENTHAL GMBHInventor: GRUNENTHAL GMBH
-
Patent number: 8460690Abstract: A process for deterring behavior of pets which includes providing a device comprising a reflective metalized plastic sheet having a thickness of about 0.5 to 10.0 mils, having a reflective and non-reflective side and capable of making a sound when the sheet is flexed by pressure from a pet, a fibrous layer, and a decorative fabric layer, where the layers are joined together to form the device, and the reflective side of said reflective plastic layer is oriented outward, where the device is capable of being folded or rolled-up, and when placed on an object, the device deters pets from getting on said object.Type: GrantFiled: March 17, 2011Date of Patent: June 11, 2013Assignee: PetzOff InternationalInventor: Jeremiah S. Downs
-
Publication number: 20130136700Abstract: A hair regrowth system consisting of sensitization, growth, and maintenance kits for alopecia areata and related alopecia balding conditions. Graduated doses of specific engineered and or extracted haptens are included in a sensitization kit for initiating immune system response in hairless areas. A growth kit containing topical hormones to increase papilla size and vigor and a maintenance kit to sustain immune system response and papilla size and vigor for the long term are included in some embodiments.Type: ApplicationFiled: November 28, 2011Publication date: May 30, 2013Inventor: George Davey
-
Patent number: 8420056Abstract: The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse and optionally physiologically acceptable adjuvants. The invention also relates to a corresponding method for producing said dosage form.Type: GrantFiled: October 11, 2011Date of Patent: April 16, 2013Assignee: Grunenthal GmbHInventors: Elisabeth Arkenau-Maric, Johannes Bartholomäus, Heinrich Kugelmann
-
Publication number: 20130034503Abstract: A method and compositions for treating a patient that prevent or reduce drug abuse and overdose events.Type: ApplicationFiled: February 14, 2012Publication date: February 7, 2013Inventors: William Wayne Howard, Sheldon Kavesh, Russell Francis Somma
-
Patent number: 8323889Abstract: The present invention relates to a process for the production of an abuse-proofed solid dosage form containing at least one active ingredient with potential for abuse and a synthetic or natural polymer with a breaking strength of =500 N, characterized in that a corresponding mixture is processed by melt extrusion with the assistance of a planetary-gear extruder.Type: GrantFiled: June 17, 2008Date of Patent: December 4, 2012Assignee: Gruenenthal GmbHInventors: Elisabeth Arkenau-Maric, Johannes Bartholomäus, Heinrich Kugelmann
-
Patent number: 8309060Abstract: An abuse-proofed, thermoformed dosage form containing, in addition to one or more active ingredients with abuse potential optionally together with physiologically acceptable auxiliary substances, at least one synthetic or natural polymer with a breaking strength of at least 500 N and to a process for the production thereof.Type: GrantFiled: January 9, 2012Date of Patent: November 13, 2012Assignee: Grunenthal GmbHInventors: Johannes Bartholomaus, Heinrich Kugelmann, Elisabeth Arkenau-Marić
-
Publication number: 20120276017Abstract: Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms that deliver a therapeutic amount of active drug in a delayed and controlled release formulation. The dosage form can be administered at night and drug release is delayed for from 3 to 8 hours, followed by an ascending release rate.Type: ApplicationFiled: March 23, 2012Publication date: November 1, 2012Inventors: David Lickrish, Feng Zhang
-
Solubilization of cyclohexane-based carboxamide derivatives for use as sensates in consumer products
Patent number: 8277824Abstract: Disclosed are methods of solubilizing various coolants, in particular cyclohexane-based carboxamide derivatives to facilitate formulating these coolants into a wide variety of consumer products, including those for oral cavity, throat, skin and hair care applications. Suitable solvents are those that provide at least 5% concentrated solutions of these coolants. Particularly preferred solvents are those used in the perfume and flavor industries and are GRAS materials that do not contribute formulation difficulties or negative aesthetics.Type: GrantFiled: August 14, 2009Date of Patent: October 2, 2012Assignee: The Procter & Gamble CompanyInventor: John Christian Haught -
Publication number: 20120201761Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.Type: ApplicationFiled: September 12, 2011Publication date: August 9, 2012Applicant: Purdue Pharma L.P.Inventor: Richard Sackler
-
Publication number: 20120107250Abstract: An abuse-proofed, thermoformed dosage form containing, in addition to one or more active ingredients with abuse potential optionally together with physiologically acceptable auxiliary substances, at least one synthetic or natural polymer with a breaking strength of at least 500 N and to a process for the production thereof.Type: ApplicationFiled: January 9, 2012Publication date: May 3, 2012Applicant: GRUENENTHAL GMBHInventors: Johannes Bartholomäus, Heinrich Kugelmann, Elisabeth Arkenau-Maric
-
Patent number: 8114383Abstract: The present invention relates to an abuse-proofed, thermoformed dosage form containing, in addition to one or more active ingredients with abuse potential optionally together with physiologically acceptable auxiliary substances, at least one synthetic or natural polymer with a breaking strength of at least 500 N and to a process for the production thereof.Type: GrantFiled: November 20, 2003Date of Patent: February 14, 2012Assignee: Gruenenthal GmbHInventors: Johannes Bartholomäus, Heinrich Kugelmann, Elisabeth Arkenau-Marić
-
Patent number: 8114384Abstract: The present invention relates to a process for the production of an abuse-proofed solid dosage form containing at least one active ingredient with potential for abuse and a synthetic or natural polymer with a breaking strength of =500 N, characterized in that a corresponding mixture is processed by melt extrusion with the assistance of a planetary-gear extruder.Type: GrantFiled: July 14, 2004Date of Patent: February 14, 2012Assignee: Gruenenthal GmbHInventors: Elisabeth Arkenau, Johannes Bartholomāus
-
Publication number: 20120034171Abstract: The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse and optionally physiologically acceptable adjuvants. The invention also relates to a corresponding method for producing said dosage form.Type: ApplicationFiled: October 11, 2011Publication date: February 9, 2012Applicant: GRUENENTHAL GMBHInventors: Elisabeth ARKENAU-MARIC, Johannes Bartholomäus, Heinrich Kugelmann
-
Patent number: 8104433Abstract: Disclosed herein are gustatory and/or olfactory aversion compositions comprising one or more bitterants and appropriate adhesives or tackifiers, and the like, which provide a long-lasting effect. The compositions are useful for behavior modification, especially in animals, such as pets or livestock.Type: GrantFiled: July 9, 2009Date of Patent: January 31, 2012Assignee: Vet Planet, LLCInventors: Richard J. Clement, Kati Clement-Frazier, legal representative
-
Patent number: 8075872Abstract: The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse and optionally physiologically acceptable adjuvants. The invention also relates to a corresponding method for producing said dosage form.Type: GrantFiled: February 6, 2006Date of Patent: December 13, 2011Assignee: Gruenenthal GmbHInventors: Elisabeth Arkenau-Maric, Johannes Bartholomäus, Heinrich Kugelmann
-
Publication number: 20110264696Abstract: A pharmaceutical dosage form is provided that has a distinguishing characteristic and an identifier associated with the dosage form. The distinguishing characteristic is assigned from a limited set of distinguishing characteristics and is determined upon oral administration of the dosage form, or is detected in breath, bodily fluids, or tissues after ingestion, or injection or other non-oral administration. The identifier is associated with the dosage form and with the distinguishing characteristic. The identifier is associated with only one distinguishing characteristic but the distinguishing characteristic may be associated with multiple identifiers. The pharmaceutical dosage form may be used in a method to monitor compliance with a dosage regimen.Type: ApplicationFiled: April 27, 2011Publication date: October 27, 2011Inventor: Joel David Selaniko
-
Publication number: 20110217243Abstract: Disclosed are methods for marking a pharmaceutical product, container or pharmaceutical packaging system with a scent to establish the identity and/or source of the pharmaceutical.Type: ApplicationFiled: September 14, 2010Publication date: September 8, 2011Applicant: Purdue Pharma L.P.Inventor: Sheryl E. SIEGEL
-
Publication number: 20100135914Abstract: A fumigant composition including an azeotropic mixture of methyl iodide and sulfuryl fluoride; and a method of controlling at least one target insect species including treating a target space with a composition including an azeotropic mixture of methyl iodide and sulfuryl fluoride by applying an amount of the composition to the target space that is effective to kill a substantial portion of the target insect species in multiple development stages.Type: ApplicationFiled: December 3, 2008Publication date: June 3, 2010Inventors: Andrew Joseph Poss, Rajiv Ratna Singh, Hang T. Pham
-
Publication number: 20080247959Abstract: The invention relates to a form of administration which is thermoformed without extrusion, comprising at least one synthetic or natural polymer having a resistance to breaking of at least 500 N in addition to one or several active ingredients with a misuse potential and, optionally physiologically compatible auxiliary substances. The invention also relates to a method for the production thereof.Type: ApplicationFiled: June 17, 2008Publication date: October 9, 2008Applicant: GRUNENTHAL GMBHInventors: Johannes Bartholomaus, Heinrich Kugelmann, Elisabeth Arkenau-Maric
-
Publication number: 20080152595Abstract: This invention relates to an abuse deterrent formulation of an oral dosage form of a therapeutically effective amount of any active drug substance that can be subject to abuse combined with a gel forming polymer, a nasal mucosal irritating surfactant and a flushing agent. Such a dosage form is intended to deter abuse of the active drug substance via injection, nasal inhalation or consumption of quantities of the dosage unit exceeding the usual therapeutically effective dose.Type: ApplicationFiled: December 12, 2007Publication date: June 26, 2008Inventors: James F. Emigh, Ronald L. Leech, Andrew D. Reddick, Ron J. Spivey
-
Patent number: 7041275Abstract: A surgical irrigating fluid composition, especially for endoscopic surgery, is provided comprising a rinsing fluid and nitrous oxide added as a marker to the rinsing fluid in an amount which is detectable in the expired breath from a mammal, especially man, that is subjected to the surgery.Type: GrantFiled: March 15, 2002Date of Patent: May 9, 2006Inventor: Robert Hahn
-
Publication number: 20040136912Abstract: A safe toy balloon and a method for making same are provided. The safe toy balloon includes an elastomeric inflatable member having an exterior surface, an interior surface, a neck portion and a body portion; and a safety coating formed on portions of the one or more of the surfaces of the inflatable member, the safety coating consisting essentially of repulsive taste agent for making uninflated and inflated balloons safer from risk of ingestion injuries or possible death from asphyxiation.Type: ApplicationFiled: December 1, 2003Publication date: July 15, 2004Inventors: Robert H. Murray, John R. Murray
-
Publication number: 20030170181Abstract: A method is provided for treating a patient with a methylphenidate-responsive condition that is at a risk of abusing or becoming addicted to methylphenidate. The patient is first evaluated for an elevated risk of drug abuse or addiction through psychological evaluations and then treated with a methylphenidate product that includes an emesis-inducing agent that is inert when ingested orally and only produces emesis when snorted or taken intravenously or a topical analgesic that is inert when ingested orally and only produces irritation when snorted or taken intravenously. The method includes delivering the methylphenidate in a pulsatile delivery system such that the emesis-inducing agent or the topical analgesic is included in one of the pulsatile dosages.Type: ApplicationFiled: December 16, 2002Publication date: September 11, 2003Inventor: Kamal K. Midha
-
Publication number: 20030170180Abstract: The invention relates to compositions of non-lethal chemical weapons for riot and crowd control. The compositions can also be used to clear areas and facilities for extended periods without collateral damage. Specifically, this invention discloses “dial an effect” non-lethal weapons for crowd control, from moderate to near lethal strength. The composition contains three unique active ingredients comprising an odoriferous substance, a hot substance, and a tear gas agent, A method is disclosed to prepare the compositions with solvents, carriers, pressurizers, and optional ingredients, as well as a method to apply them.Type: ApplicationFiled: November 12, 2002Publication date: September 11, 2003Inventor: William S. Bahary
-
Publication number: 20030068276Abstract: Solid oral dosage forms of controlled substances containing aversive agents are useful in reducing abuse by chewing or inhaling.Type: ApplicationFiled: November 2, 2001Publication date: April 10, 2003Inventors: Lyn Hughes, Simon Andrew Bellamy
-
Publication number: 20020106329Abstract: A distressing substance is added to opioid analgesic compositions intended for percutaneous administration, in order to prevent drug abuse.Type: ApplicationFiled: October 25, 2001Publication date: August 8, 2002Inventor: Stewart Thomas Leslie
-
Patent number: 6337080Abstract: An insect control mat having a heatable substrate; an insect control active material; and an aversion material in an amount effective to cause a person to avoid retaining the mat in the person's mouth. A method of controlling insects by use of such a mat is also disclosed.Type: GrantFiled: December 21, 1999Date of Patent: January 8, 2002Assignee: S. C. Johnson & Son, Inc.Inventors: Michael C. Fryan, James J. Olson